Henry Schein (HSIC) announced that its Board of Directors has authorized the repurchase of up to $750M of shares of the Company’s common stock. This program is in addition to the $500M repurchase program announced in January, which is anticipated to be fully executed by the end of the Q1 of 2026. The Company had approximately 118.6 million shares outstanding as of September 8. This new authorization represents approximately 9.0 percent of shares outstanding at the current stock price. Purchases may be made from time to time in the open market, or through negotiated transactions.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSIC:
- Henry Schein’s Senior Advisor James Breslawski Departs
- Early notable gainers among liquid option names on August 26th
- Henry Schein upgraded to Outperform from In Line at Evercore ISI
- Henry Schein price target lowered to $70 from $75 at UBS
- Henry Schein price target lowered to $78 from $86 at Barrington